VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO GI 2021 | Novel approaches in the treatment of GI malignancies

Joshua E. Meyer • 20 Jan 2021
ASCO GI 2021
Gastrointestinal Cancer Rectal Cancer

Joshua E. Meyer, MD, Fox Chase Cancer Center, Philadelphia, PA, discusses upcoming advances in rectal cancer and highlights the importance of a personalized approach to treating this patient population. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Genomic biomarkers in metastatic colorectal cancer

More from Joshua E. Meyer

2:25
Adjuvant therapy for esophageal cancer
Joshua E. Meyer • 20 Jan 2021
3:05
Alliance A021501: preoperative mFOLFIRINOX +/- hypofractionated RT for pancreatic cancer
Joshua E. Meyer • 20 Jan 2021

Related Videos

4:31
Colorectal cancer subtyping using a histology based approach
Joanne Edwards
2:13
HER-2 conversion: a phenomenon in trastuzumab resistance
Russell Petty
2:25
Current therapies for advanced HCC and their limitations
Michael Pishvaian
3:40
The gut microbiome: role in causing and detecting colorectal cancer
Paul O'Toole
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals